Below you'll find case studies, webinars, blogs, and press releases where we share valuable insights about decentralized clinical trials.
A baby nutrition client sought to create a database of stool images that could be used for internal software development purposes.
To assess the GI tolerability of different combinations of infant formula ingredients.
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
A Fortune 500 multinational packaged foods company sought to drive growth in a legacy fiber snack bar brand by launching new product line extensions with a re-formulated fiber ingredient.
A multinational food company needed to assess the safety and efficacy of rice vinegar as a treatment for pre-hypertensive adults, and those at high risk of Cardiovascular disease.
It is notoriously difficult to conduct studies with cohorts of young children and their caregivers due to participant burden and subjectivity in patient-reported outcomes. This fully virtual study, the first of its kind targeting infants and caregivers, will leverage digital instruments and AI to capture and quantify infant cries as a key outcome for colic symptoms and quality-of-life endpoints.
Virtual clinical trials aren’t just a buzzword—these research models are here to stay. In fact, the global market for virtual clinical trials is expected to reach $12.9 billion by 2030, according to Grand View Research.
This study sought to monitor COVID-19 prevalence and course of symptoms among oncology patients in order to identify any correlations with the biological and clinical data collected from the oncology cohort.